维普中文期刊产品整合服务
478篇 您的检索式:作者名="Bell C M"
    题名 作者 年代 出处 被引量
1Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience显示文摘AIM To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary care setting.METHODS We performed a retrospective analysis of treatment outcomes among treatment-na?ve and treatment-experienced patients receiving a minimum 3 mo tenofovir therapy through St Vincent's Hospital Melbourne, Australia. We included patients receiving tenofovir [tenofovir disoproxil fumarate(TDF)] monotherapy, as well as patients treated with TDF in combination with a second antiviral agent. Patients were excluded if they demonstrated human immune-deficiency virus/hepatitis C virus/hepatitis delta virus coinfection or were less than 18 years of age. We considered virological and biochemicalresponse, as well as safety outcomes. Virological response was determined by measurement of hepatitis B virus(HBV) DNA using sensitive assays; biochemical response was determined via serum liver function tests; histological response was determined from liver biopsy and fibroscan; safety analysis focused on glomerular renal function and bone mineral density. The primary efficacy endpoint was complete virological suppression over time, defined by HBV DNA < 20 IU/m L. Secondary efficacy endpoints included rates of biochemical response, and HB e antigen(HBe Ag)/HB surface antigen loss and seroconversion over time.RESULTS Ninety-two patients were identified who fulfilled the enrolment criteria. Median follow-up was 26 mo(range 3-114). Mean age was 46(24-78) years, 64(70%) were male and 77(84%) were of Asian origin. 55(60%) patients were treatment-na?ve and 62 patients(67%) were HBe Ag-negative. Complete virological suppression was achieved by 45/65(71%) patients at 12 mo, 37/46(80%) at 24 mo and 25/28(89%) at 36 mo. Partial virological response(HBV DNA 20-2000 IU/m L) was achieved by 89/92(96.7%) of patients. Multivariate analysis showed a significant relationship between virological suppression at end of follow-up and baseline HBV DNA level(OR = 0.897, 95%CI: 0.833-0.967, P = 0.0046) and HBe Ag positive status(OR = 0.373, 95%CI: 0.183-0.762, P = 0.0069). There was no difference in response comparing treatment-na?ve and treatment-experienced patients. Three episodes of virological breakthrough occurred in the setting of noncompliance. Tenofovir therapy was well tolerated.CONCLUSION Tenofovir is an efficacious, safe and well-tolerated treatment in an Australian real-world tertiary care setting. Our data are similar to the reported experience from registration trials.Grace C Lovett Tin Nguyen David M Iser Jacinta A Holmes Robert Chen Barbara Demediuk Gideon Shaw Sally J Bell Paul V Desmond Alexander J Thompson 2017World Journal of Hepatology2017,9,1:7
2Requirement of the auxin polar transport system in early stages of Arabidopsis floral bud formation显示文摘OKADA K UEADA J KOMAKI M K BELL C J SHIMURA Y 1991Plant Cell1991,3,7:1
3Visual Interactive Simulation-Histroy,Recent Developments and Major Issues显示文摘 Robert M O'Keefe 1987Simulation1987,49,3:1
4Peanut leaf photosynthetic activity in cool field environments显示文摘Bell M J Gillespie T J Roy R C 1994Crop Science1994,34,4:1
5Weight gain and its predictors in Chinese adults 显示文摘BELL A C GE K POPKIN B M 2001Int J Obsity2001,25,:1
6Rep-PCR-mediated genomic fingerprinting:a rapid and effective method to identify Clavibacter michiganensis显示文摘Louws F J Bell J Medina-Mora C M 1998Phytopathology1998,88,:1
7Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation 显示文摘Bell C Dowson N Fay M 2015Semin Nucl Med2015,45,2:1
8Hepatic de novo lipogenesis in stable low-birth-weight infants during exclusive breast milk feedings and during parenteral nutrition 显示文摘Garg M Bassilian S Bell C 2005JPEN J Parenter Enteral Mutr2005,29,2:1
9Serum 25-hydroxyvitamin D,diabetes,and ethnicity in the Third National Health and Nutrition Examination Survey显示文摘Scragg R Sowers M Bell C 2004Diabetes Care2004,27,:1
10BirA En- zyme: Production and Application in the Study of Mem- brane Receptor - Ligand Interactions by Site-Specific Biotinylation Original Research 显示文摘O'Callaghan C A Byford M F Wyer J R Willcox BE Jakobsen B K McMichael A J Bell J 1 1999Anal Biochem1999,266,1:1
11A comparison of complications associated with colostomy revered versus ileostomy reversal显示文摘Bell C Asolati M Hamilton E 2005J Am Coll Surg2005,190,:1
12Dietary lipid enhancement of broodstock reproductive performance and egg and larval quality in Atlantic halibut(Hippoglossus hippoglossus)显示文摘Mazorra C Bruce M Bell J G 2003Aquaculture2003,227,:1
13Assignment in the integration of urban traffic control and dynamic route guidance,in urban traffic networks dynamic flow modeling and control显示文摘Bell M G H Shield C M Anderson J M 1995Springer-Verlag1995,,:1
14Diversity waveform sets for delay-Doppler imaging显示文摘Guey J C Bell M R 0,,4:1
15Optical sampling and demultiplexing applied to A/D conversion显示文摘 Hamilton M C Leep D A 1991Proc SPIE1991,1562,:1
16Magnetic resonance imaging of central nervous system lesions in patients withlupus erythematosus: correlation with clinical remission and antineurofilament and anticardiolipin titers 显示文摘Bell CL Partington C Robbins M 1997Arthritis Rheum1997,34,5:1
17Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method 显示文摘Leslie H Courtney C H Bell P M 2001J Clin Endocrinol Metab2001,86,6:1
18XPD codon 751 polymorphism,metabolism genes,smoking,and bladder cancer risk显示文摘STERN M C JOHNSON L R BELL D A 2002Cancer Epidemiol Biomarkers Prev2002,11,101:1
19Origins of long-chain polyunsaturated fatty acids in the hydrothermal vent worms Ridgea pisceae and Protis hydrothermica显示文摘POND D W ALLEN C E BELL M V 2002Marine Ecology Progress Series2002,225,:1
20Film Cooling From Shaped Holes 显示文摘Bell C M Hamakawa H Ligrani P M 2000Journal of Turbomachinery2000,122,:1
返回顶部 每页显示:
共24页 首页 上一页 第1页 下一页 末页 /24 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费